Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 2, 2022
Patent Application Number
17340885
Date Filed
June 7, 2021
Patent Citations
Patent Citations Received
...
Patent Primary Examiner
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
